CellaVision AB (LTS:0MR5) Other Long-Term Liabilities : kr75.5 Mil (As of Dec. 2024)

View and export this data going back to 2016. Start your Free Trial

What is CellaVision AB Other Long-Term Liabilities?

CellaVision AB's other long-term liabilities for the quarter that ended in Dec. 2024 was kr75.5 Mil.

CellaVision AB's quarterly other long-term liabilities increased from Jun. 2024 (kr69.7 Mil) to Sep. 2024 (kr71.6 Mil) and increased from Sep. 2024 (kr71.6 Mil) to Dec. 2024 (kr75.5 Mil).

CellaVision AB's annual other long-term liabilities increased from Dec. 2022 (kr56.7 Mil) to Dec. 2023 (kr64.5 Mil) and increased from Dec. 2023 (kr64.5 Mil) to Dec. 2024 (kr75.5 Mil).

CellaVision AB Other Long-Term Liabilities Historical Data

The historical data trend for CellaVision AB's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CellaVision AB Other Long-Term Liabilities Chart

CellaVision AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Long-Term Liabilities

Get a 7-Day Free Trial

47.36

51.59

56.66

64.51

75.54

CellaVision AB Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Other Long-Term Liabilities	Get a 7-Day Free Trial															64.51	67.82	69.70	71.60	75.54

CellaVision AB Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

CellaVision AB Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of CellaVision AB's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

CellaVision AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CellaVision AB (LTS:0MR5) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

CEVI:Sweden CEVIs:UK C26:Germany C26:Germany

Address

Mobilvagen 12, Lund, SWE, 22362

Website

https://www.cellavision.com

CellaVision AB is engaged in the business of supplying digital solutions for blood and body fluid analysis. Its solutions are based on digital image analysis technology, artificial intelligence, and information technology. The firm's product portfolio consists of CellaVision peripheral blood application, CellaVision advanced RBC application, and CellaVision remote review software. Its customers include mainly large hospital laboratories and commercial laboratories in North America, Europe and China, and Japan. The company derives the majority of its revenue from the sale of analyzers or software.

CellaVision AB Headlines

No Headlines